Herein, We used Immunohistochemistry to characterize CD44 expression levels on the surface of MCF-7 and BT-20 breast cancer cells, as shown in (Figure 11b) proved that MCF-7 was negative CD44, while BT-20 showed positive CD44 [22]. The gene discussed is CD44; the disease is breast carcinoma.